Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo

J Neurosci. 2002 Sep 1;22(17):7453-61. doi: 10.1523/JNEUROSCI.22-17-07453.2002.

Abstract

Acute intrahippocampal infusion of brain-derived neurotrophic factor (BDNF) leads to long-term potentiation (BDNF-LTP) of synaptic transmission at medial perforant path-->granule cell synapses in the rat dentate gyrus. Endogenous BDNF is implicated in the maintenance of high-frequency stimulation-induced LTP (HFS-LTP). However, the relationship between exogenous BDNF-LTP and HFS-LTP is unclear. First, we found that BDNF-LTP, like HFS-LTP, is associated with enhancement in both synaptic strength and granule cell excitability (EPSP-spike coupling). Second, treatment with a competitive NMDA receptor (NMDAR) antagonist blocked HFS-LTP but had no effect on the development or magnitude of BDNF-LTP. Thus, NMDAR activation is not required for the induction or expression of BDNF-LTP. Formation of stable, late phase HFS-LTP requires mRNA synthesis and is coupled to upregulation of the immediate early gene activity-regulated cytoskeleton-associated protein (Arc). Local infusion of the transcription inhibitor actinomycin D (ACD) 1 hr before or immediately before BDNF infusion inhibited BDNF-LTP and upregulation of Arc protein expression. ACD applied 2 hr after BDNF infusion had no effect, defining a critical time window of transcription-dependent synaptic strengthening. Finally, the functional role of BDNF-LTP was assessed in occlusion experiments with HFS-LTP. HFS-LTP was induced, and BDNF was infused at time points corresponding to early phase (1 hr) or late phase (4 hr) HFS-LTP. BDNF applied during the early phase led to normal BDNF-LTP. In contrast, BDNF-LTP was completely occluded during the late phase. The results strongly support a role for BDNF in triggering transcription-dependent, late phase LTP in the intact adult brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor / pharmacokinetics
  • Brain-Derived Neurotrophic Factor / pharmacology*
  • Cytoskeletal Proteins
  • Drug Administration Routes
  • Electric Stimulation / methods
  • Excitatory Amino Acid Antagonists / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology
  • Hippocampus / drug effects*
  • Hippocampus / physiology
  • Immediate-Early Proteins / metabolism
  • Long-Term Potentiation / drug effects*
  • Long-Term Potentiation / physiology
  • Nerve Tissue Proteins*
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / physiology
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Tissue Distribution
  • Transcription, Genetic / drug effects*
  • Transcription, Genetic / physiology
  • Up-Regulation / drug effects

Substances

  • Brain-Derived Neurotrophic Factor
  • Cytoskeletal Proteins
  • Excitatory Amino Acid Antagonists
  • Immediate-Early Proteins
  • Nerve Tissue Proteins
  • Nucleic Acid Synthesis Inhibitors
  • Receptors, N-Methyl-D-Aspartate
  • activity regulated cytoskeletal-associated protein